FGF21 and Cirrhosis: Increased plasma levels of the hepatokine Fibroblast Growth Factor 21 (FGF-21) are associated with hepatic steatosis [27], but low levels of FGF-21 are associated with advanced fibrosis/cirrhosis in patients with CHB.